Integral Molecular is a research-driven biotechnology company creating innovative technologies and therapeutic antibodies for under-exploited membrane protein targets, including GPCRs, ion channels, transporters, and viral envelopes.

20+ years experience optimizing membrane proteins

Work with Top 20 pharmaceutical companies

400+ customers and partners

Upcoming Events

ACT 2022 Annual Meeting
11/13 -11/16| Denver, CO
PEGS Europe
11/14 -11/16 | Barcelona, Spain
Antibody Engineering & Therapeutics
12/4 – 12/8 | San Diego, California